Townsend & Associates, Inc - ARRAY BIOPHARMA INC ownership

Quarter-by-quarter ownership
Townsend & Associates, Inc ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q3 2018$8,000
-11.1%
5550.0%0.01%
-20.0%
Q2 2018$9,0000.0%5550.0%0.01%
+42.9%
Q1 2018$9,0005550.01%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 16,618,776$146,079,00012.59%
BVF INC/IL 4,986,186$43,829,0008.81%
First Light Asset Management, LLC 1,000,361$8,793,0003.86%
Crosspoint Capital Strategies, LLC 463,005$4,070,0003.62%
Consonance Capital Management LP 2,723,471$23,912,0002.63%
KOPP INVESTMENT ADVISORS LLC 219,926$1,933,0002.04%
SPHERA FUNDS MANAGEMENT LTD. 900,000$7,911,0002.00%
Orbimed Advisors 16,088,800$141,421,0001.80%
Cormorant Asset Management, LP 1,150,000$10,109,0001.36%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 2,073,680$18,227,0001.26%
View complete list of ARRAY BIOPHARMA INC shareholders